Cargando…
RARE-11. QUANTITATIVE MR IMAGING FEATURES ASSOCIATED WITH UNIQUE TRANSCRIPTIONAL CHARACTERISTICS IN PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA: A POTENTIAL GUIDE FOR THERAPY
METHODS: Through the Advancing Treatment for Pediatric Craniopharyngioma (ATPC) consortium we accumulated preoperative MRIs and tumor RNA for 50 unique ACP patients. MRIs were assessed quantitatively for 28 different features and analyzed using Multiple Factor Analysis (MFA) and optimal clustering w...
Autores principales: | Mirsky, David, Prince, Eric, Staulcup, Susan, Hengartner, Astrid, Vijmasi, Trinka, Johnston, James, Massimi, Luca, Anderson, Richard, Souweidane, Mark, Naftel, Robert, Limbrick, David, Grant, Gerald, Niazi, Toba, Dudley, Roy, Kilburn, Lindsay, Jackson, Eric, Jallo, George, Ginn, Kevin, Smith, Amy, Chern, Joshua, Lee, Amy, Drapeau, Annie, Krieger, Mark, Handler, Michael, Hankinson, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715942/ http://dx.doi.org/10.1093/neuonc/noaa222.722 |
Ejemplares similares
-
RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
por: Trudeau, Tammy, et al.
Publicado: (2022) -
RARE-08. CYST FLUID CYTOKINES MAY PROMOTE EPITHELIAL-TO-MESENCHYMAL TRANSITION IN PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA
por: Vijmasi, Trinka, et al.
Publicado: (2020) -
RARE-10. ADAMANTINOMATOUS CRANIOPHARYNGIOMA RESIDES OUTSIDE THE BLOOD BRAIN BARRIER
por: Prince, Eric, et al.
Publicado: (2020) -
RARE-32. Phase 0 and feasibility single-institution clinical trial of intravenous tocilizumab for adamantinomatous craniopharyngioma
por: Dorris, Kathleen, et al.
Publicado: (2022) -
QOL-22. MACHINE-LEARNING INFERENCE MAY PREDICT QUALITY OF LIFE SUBGROUPS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA
por: Hengartner, Astrid C, et al.
Publicado: (2020)